Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Tatva Chintan Pharma Chem Annual General Meeting

Tatva Chintan Pharma Chem Limited has scheduled its 30th Annual General Meeting for September 25, 2026. Key agenda items include dividend declaration and director re-appointments.

Source

BSE filing, NSE: TATVA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Tatva Chintan Pharma Chem Ltd: key numbers

Share price
₹1,627.80
Market cap
₹3,808 Cr
Revenue (annual)
₹505.9 Cr
Net profit (annual)
₹42.05 Cr
P/E (TTM)
60.5×Sector 34.1×
Promoter holding
72.02%+0.00% QoQ
FII holding
4.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Tatva Chintan Pharma Chem Ltd

All →

Other annual general meeting announcements

All →